787 related articles for article (PubMed ID: 7484707)
1. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
2. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities and limits of oral diabetes therapy].
Bruneder H
Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
[No Abstract] [Full Text] [Related]
4. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
5. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
Graham JP; Stam D
Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
[TBL] [Abstract][Full Text] [Related]
6. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
Ponte CD
W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
[TBL] [Abstract][Full Text] [Related]
7. [Oral antidiabetic agents: recent aspects].
Keller U; Berger W
Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
[TBL] [Abstract][Full Text] [Related]
8. [Knack of treatment with oral hypoglycemic drugs in the elderly].
Komatsu M; Hashizume K
Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454
[TBL] [Abstract][Full Text] [Related]
9. Oral antihyperglycaemics. Considerations in older patients with non-insulin-dependent diabetes mellitus.
Jennings PE
Drugs Aging; 1997 May; 10(5):323-31. PubMed ID: 9143853
[TBL] [Abstract][Full Text] [Related]
10. Treating type 2 diabetes: targeting the many causative factors.
Sutherland JE; Hoehns JD
J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
[No Abstract] [Full Text] [Related]
11. Insulin: either alone or combined with oral hypoglycemic agents.
Firth RG
Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
[TBL] [Abstract][Full Text] [Related]
12. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
13. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
Albert J; Ekoé JM
Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic utility of biguanides in the treatment of NIDDM].
Fujimoto S
Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
16. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
Bressler R; Johnson DG
Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
[TBL] [Abstract][Full Text] [Related]
17. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
Bell DS
Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
[TBL] [Abstract][Full Text] [Related]
18. Use of sulfonylurea agents in older diabetic patients.
Peters AL; Davidson MB
Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of type-II diabetes: tablets, insulin or a combination of these].
Diem P
Schweiz Rundsch Med Prax; 1994 Jan; 83(3):68-71. PubMed ID: 8296132
[TBL] [Abstract][Full Text] [Related]
20. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
